Mehr Law Group Launches New Campaign to Help Victims of Blood Thinner Pradaxa®
Product liability attorneys Mehr Law Group have launched a new campaign to help consumers who have been injured by the popular blood thinner Pradaxa®. Consumers with Pradaxa® blood thinner injuries are encouraged to call Mehr Law Group today.
Irvine, CA, February 21, 2013 --(PR.com)-- Product liability attorneys Mehr Law Group launched a new campaign today to help victims of Pradaxa®, a popular blood thinner medication. Consumers who believe they have been injured taking Pradaxa® are encouraged to call the product liability attorneys at Mehr Law Group today. Mehr Law Group is offering injured consumers a free consultation to discuss potential Pradaxa® blood thinner injuries and available compensation.
Said attorney Mark Sweet, "We've heard cases where a Pradaxa® patient has bled to death as the result of a slip and fall. We find this horrifying and would like to offer patients and their loved ones free consultations to determine how Mehr Law Group might be able to help."
Pradaxa® (dabigatran) is one of the most popular blood thinner medications on the market today. Taken by consumers with atrial fibrillation, Pradaxa® blood thinner is intended to prevent potentially deadly blood clots that could accumulate and cause a stroke. However, the FDA reports that Pradaxa® may be riskier than earlier believed. Marketed as a safer alternative to Warfarin®, Pradaxa® differs significantly because it does not have a reversal agent. Should patients begin to bleed out, they could potentially bleed to death. The FDA asserts Pradaxa® has been linked to 540 deaths in 2011 and thousands of reported adverse side effects out of the over 3.7 million prescriptions in America. (http://www.fda.gov/Drugs/DrugSafety/ucm332912.htm)
Based on the number of reported adverse bleeding events and deaths, lawsuits have sprung up across America. Injured consumers have claimed Pradaxa® manufacturer, Boehringer Ingelheim aggressively marketed the blood thinner as a safe alternative to existing blood thinners without taking patient safety into account. The Pradaxa® blood thinner lawsuits have been consolidated into multidistrict litigation in the U.S. District Court of Illinois case number 12-MD-2385. Litigation is expected to begin in March 2014.
The product liability attorneys Mehr Law Group would like to help consumers who have been injured taking their Pradaxa® medication. The firm encourages injured consumers to call (800) 908-8124 today to discuss their case.
About Mehr Law Group:
The product liability attorneys at Mehr Law Group have decades of experience fighting for the rights of injured consumers. These passionate and skilled product liability attorneys desire to obtain the best possible outcome for injured consumers. To obtain help, consumers are encouraged to call Mehr Law Group at (800) 908-8124 or visit http://www.mehrlawgroup.com
Said attorney Mark Sweet, "We've heard cases where a Pradaxa® patient has bled to death as the result of a slip and fall. We find this horrifying and would like to offer patients and their loved ones free consultations to determine how Mehr Law Group might be able to help."
Pradaxa® (dabigatran) is one of the most popular blood thinner medications on the market today. Taken by consumers with atrial fibrillation, Pradaxa® blood thinner is intended to prevent potentially deadly blood clots that could accumulate and cause a stroke. However, the FDA reports that Pradaxa® may be riskier than earlier believed. Marketed as a safer alternative to Warfarin®, Pradaxa® differs significantly because it does not have a reversal agent. Should patients begin to bleed out, they could potentially bleed to death. The FDA asserts Pradaxa® has been linked to 540 deaths in 2011 and thousands of reported adverse side effects out of the over 3.7 million prescriptions in America. (http://www.fda.gov/Drugs/DrugSafety/ucm332912.htm)
Based on the number of reported adverse bleeding events and deaths, lawsuits have sprung up across America. Injured consumers have claimed Pradaxa® manufacturer, Boehringer Ingelheim aggressively marketed the blood thinner as a safe alternative to existing blood thinners without taking patient safety into account. The Pradaxa® blood thinner lawsuits have been consolidated into multidistrict litigation in the U.S. District Court of Illinois case number 12-MD-2385. Litigation is expected to begin in March 2014.
The product liability attorneys Mehr Law Group would like to help consumers who have been injured taking their Pradaxa® medication. The firm encourages injured consumers to call (800) 908-8124 today to discuss their case.
About Mehr Law Group:
The product liability attorneys at Mehr Law Group have decades of experience fighting for the rights of injured consumers. These passionate and skilled product liability attorneys desire to obtain the best possible outcome for injured consumers. To obtain help, consumers are encouraged to call Mehr Law Group at (800) 908-8124 or visit http://www.mehrlawgroup.com
Contact
Mehr Law Group
Catherine Hess
(800) 908-8124
www.mehrlawgroup.com
Catherine Hess
(800) 908-8124
www.mehrlawgroup.com
Contact
Categories